Benzinga | Jan 13, 2022 11:47AM EST

Piper Sandler Maintains Overweight on Blend Labs, Lowers Price Target to $10

Piper Sandler analyst Arvind Ramnani maintains Blend Labs (NYSE:BLND) with a Overweight and lowers the price target from $13 to $10.